HYPERA (HYPE3) Main Indicators
Basic Data - HYPE3
| Company | HYPERA |
| Corporate Name | HYPERA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Fabricacão de Medicamentos Alopáticos para uso humano |
| Share | HYPE3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 20.50 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 105.01 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | GPTW, IBOVESPA, IBRA, IBRX, IBRX50, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
| Updated 11/21/2024 | |
Relative Prices - HYPE3
| Price/Earnings | 8.28 |
| Price/SBV | 1.06 |
| Price/Net Sales | 1.67 |
| Price/CFO | 4.93 |
| Price/FCF | 5.78 |
| Price/Total Assets | 0.50 |
| Price/EBIT | 5.72 |
| Price/Working Capital | 3.29 |
| Price/NCAV | -1.34 |
| EV/EBIT | 8.84 |
| EV/EBITDA | 7.88 |
| EV/Net Sales | 2.58 |
| EV/CFO | 7.62 |
| EV/FCF | 8.92 |
| EV/Total Assets | 0.78 |
| Company Market Cap | R$ 12.99 B |
| Enterprise Value | R$ 20.06 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 20.50 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 5.78% |
| Updated 11/21/2024 | |
Income Statement - HYPE3
| Net Revenue | R$ 7.78 B |
| Gross Result | R$ 4.74 B |
| EBIT | R$ 2.27 B |
| Depreciation and Amortization | - R$ 274.88 M |
| EBITDA | R$ 2.54 B |
| Net Profit | R$ 1.57 B |
| Net Profit/Share | R$ 2.48 |
| Updated 11/13/2024 | |
| Net Revenue | R$ 1.92 B |
| Gross Result | R$ 1.15 B |
| EBIT | R$ 491.33 M |
| Depreciation and Amortization | - R$ 69.87 M |
| EBITDA | R$ 561.20 M |
| Net Profit | R$ 376.38 M |
| Profit/Share | R$ 0.59 |
| Updated 11/13/2024 | |
Price and Volume Behavior - HYPE3
| Lowest Price 52 weeks | R$ 20.50 |
| Highest Price 52 weeks | R$ 35.23 |
| Variation 2024 | -39.95% |
| Variation 1 year | -38.63% |
| Variation 2 years(total) | -50.93% |
| Variation 2 years(yearly) | -29.88% |
| Variation 3 years(total) | -21.58% |
| Variation 3 years(yearly) | -7.78% |
| Variation 4 years(total) | -24.79% |
| Variation 4 years(yearly) | -6.87% |
| Variation 5 years(total) | -27.64% |
| Variation 5 years(yearly) | -6.26% |
| Average Daily Volume (3 months) | R$ 155.08 M |
| Updated 11/21/2024 | |
Returns and Margins - HYPE3
| Return on Initial Tangible Capital | 18.24% |
| Return on Initial Invested Capital | 7.88% |
| Pre-Tax Return on Initial Tangible Capital | 27.64% |
| Pre-Tax Return on Initial Invested Capital | 11.94% |
| Return on Initial Shareholder´s Equity | 13.77% |
| Return on Initial Asset | 6.46% |
| Gross Margin | 60.95% |
| Net Margin | 20.16% |
| EBIT Margin | 29.18% |
| EBITDA Margin | 32.72% |
| Initial Asset Turnover | 0.32 |
| Financial Leverage | 2.12 |
| Liabilities/Net Worth | 1.12 |
| Net Debt/EBITDA | 2.78 |
| Updated 11/13/2024 | |
Balance Sheet - HYPE3
| Cash and Cash Equivalents | R$ 3.21 B |
| Total Assets | R$ 25.87 B |
| Short-Term Debt | R$ 1.96 B |
| Long-Term Debt | R$ 8.32 B |
| Gross Debt | R$ 10.28 B |
| Net Debt | R$ 7.07 B |
| Shareholder´s Equity | R$ 12.21 B |
| Share Book Value | R$ 19.28 |
| Common Shares | 633,420,823 |
| Preferred Shares | 0 |
| Total | 633,420,823 |
| Common Shares in Treasury | 738,554 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 738,554 |
| Common Shares (Except Treasury) | 632,682,269 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 632,682,269 |
| Updated 11/13/2024 | |
Cash Flow - HYPE3
| Operating Cash Flow | R$ 2.63 B |
| Cash Flow from Investments | - R$ 544.50 M |
| Financing Cash Flow | - R$ 1.10 B |
| Increase (Reduction) in Cash and Equivalents | R$ 990.22 M |
| Updated 11/13/2024 | |
| Operating Cash Flow | R$ 738.07 M |
| Cash Flow from Investments | - R$ 137.66 M |
| Financing Cash Flow | - R$ 227.90 M |
| Increase (Reduction) in Cash and Equivalents | R$ 372.51 M |
| Updated 11/13/2024 | |
Experimental - HYPE3
| CAPEX 3 months | - R$ 107.49 M |
| Free Cash Flow 3 months | R$ 630.58 M |
| CAPEX 12 months | - R$ 386.18 M |
| Free Cash Flow 12 months | R$ 2.25 B |
| Updated 11/13/2024 | |